These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18774720)

  • 61. Dual-acting diether derivatives of piperidine and homopiperidine with histamine H(3) receptor antagonistic and anticholinesterase activity.
    Bajda M; Kuder KJ; Lażewska D; Kieć-Kononowicz K; Więckowska A; Ignasik M; Guzior N; Jończyk J; Malawska B
    Arch Pharm (Weinheim); 2012 Aug; 345(8):591-7. PubMed ID: 22549828
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities.
    Grassmann S; Apelt J; Sippl W; Ligneau X; Pertz HH; Zhao YH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    Bioorg Med Chem; 2003 May; 11(10):2163-74. PubMed ID: 12713826
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K; Cumming P; Minuzzi L
    Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
    Sadek B; Schwed JS; Subramanian D; Weizel L; Walter M; Adem A; Stark H
    Eur J Med Chem; 2014 Apr; 77():269-79. PubMed ID: 24650714
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Merighi S; Varani K; Borea PA
    J Med Chem; 2005 Jul; 48(14):4697-701. PubMed ID: 16000006
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.
    Janssens F; Leenaerts J; Diels G; De Boeck B; Megens A; Langlois X; van Rossem K; Beetens J; Borgers M
    J Med Chem; 2005 Mar; 48(6):2154-66. PubMed ID: 15771458
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural modifications in the distal, regulatory region of histamine H
    Szczepańska K; Pockes S; Podlewska S; Höring C; Mika K; Latacz G; Bednarski M; Siwek A; Karcz T; Nagl M; Bresinsky M; Mönnich D; Seibel U; Kuder KJ; Kotańska M; Stark H; Elz S; Kieć-Kononowicz K
    Eur J Med Chem; 2021 Mar; 213():113041. PubMed ID: 33261900
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists.
    Dandu RR; Lyons JA; Raddatz R; Huang Z; Aimone LD; Hudkins RL
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2151-3. PubMed ID: 22365751
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
    Hedfors A; Appelqvist T; Carlsson B; Bladh LG; Litten C; Agback P; Grynfarb M; Koehler KF; Malm J
    J Med Chem; 2005 May; 48(9):3114-7. PubMed ID: 15857115
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
    Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S
    Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
    Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
    Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
    Incerti M; Flammini L; Saccani F; Morini G; Comini M; Coruzzi M; Barocelli E; Ballabeni V; Bertoni S
    ChemMedChem; 2010 Jul; 5(7):1143-9. PubMed ID: 20512794
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bivalent dopamine D2 receptor ligands: synthesis and binding properties.
    Kühhorn J; Hübner H; Gmeiner P
    J Med Chem; 2011 Jul; 54(13):4896-903. PubMed ID: 21599022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.
    Soulier JL; Russo O; Giner M; Rivail L; Berthouze M; Ongeri S; Maigret B; Fischmeister R; Lezoualc'h F; Sicsic S; Berque-Bestel I
    J Med Chem; 2005 Oct; 48(20):6220-8. PubMed ID: 16190749
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives.
    Apelt J; Grassmann S; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    Pharmazie; 2005 Feb; 60(2):97-106. PubMed ID: 15739896
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
    Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Histamine H3 receptor antagonists: from target identification to drug leads.
    Bonaventure P; Letavic M; Dugovic C; Wilson S; Aluisio L; Pudiak C; Lord B; Mazur C; Kamme F; Nishino S; Carruthers N; Lovenberg T
    Biochem Pharmacol; 2007 Apr; 73(8):1084-96. PubMed ID: 17129577
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor.
    Heitman LH; Oosterom J; Bonger KM; Timmers CM; Wiegerinck PH; Ijzerman AP
    Mol Pharmacol; 2008 Feb; 73(2):518-24. PubMed ID: 17989351
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
    Walter M; von Coburg Y; Isensee K; Sander K; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5879-82. PubMed ID: 20728354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.